Home › Marina Biotech and Mirna Therapeutics Amend License Agreement for the ...
 

Keywords :   


Marina Biotech and Mirna Therapeutics Amend License Agreement for the ...

2014-01-03 03:24:21| Biotech - Topix.net

Under terms of the amendment, Mirna paid certain pre-payments to Marina Biotech and now has additional rights to its lead program, MRX34, currently in Phase 1 clinical development for patients with unresectable primary liver cancer or metastatic cancer with liver involvement.

Tags: the agreement license marina

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
20.05Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05Several pork priorities secured in House Farm Bill
20.05BT scraps digital landline switch deadline
20.05Essie Introduces Nail Art Studio
20.05Ilia Beauty Introduces Vegan Lip Sketch Hydrating Crayon
20.05Summer interest rate cut possible, says Bank deputy
20.05Eastern North Pacific Tropical Weather Outlook
More »